Latest filing published 23 Sept 2026 for NeuPath Health Inc., €10k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Zaffirios Zygouras discloses dealings in NeuPath Health Inc. to SEDI. Over a trading history stretching from 11 June 2026 to 23 September 2026, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €10k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant.
Most recently, on 23 September 2026, the filings show an open-market purchase worth €10k in NeuPath Health Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations